Egypt
· Delayed Price · Currency is EGP NIPH Statistics
Total Valuation
EI- Nile Co. for Pharmaceuticals and Chemical Industries has a market cap or net worth of EGP 587.96 million. The enterprise value is 1.08 billion.
| Market Cap | 587.96M |
| Enterprise Value | 1.08B |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | Nov 19, 2024 |
Share Statistics
EI- Nile Co. for Pharmaceuticals and Chemical Industries has 10.13 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 10.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.95% |
| Owned by Institutions (%) | n/a |
| Float | 2.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 43.66 |
| EV / Sales | 1.22 |
| EV / EBITDA | n/a |
| EV / EBIT | 14.47 |
| EV / FCF | -4.20 |
Financial Position
The company has a current ratio of 1.10, with a Debt / Equity ratio of 1.11.
| Current Ratio | 1.10 |
| Quick Ratio | 0.29 |
| Debt / Equity | 1.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.97 |
| Interest Coverage | 2.91 |
Financial Efficiency
Return on equity (ROE) is 4.98% and return on invested capital (ROIC) is 5.57%.
| Return on Equity (ROE) | 4.98% |
| Return on Assets (ROA) | 3.48% |
| Return on Capital (ROIC) | 5.57% |
| Revenue Per Employee | 354,249 |
| Profits Per Employee | 9,859 |
| Employee Count | 2,500 |
| Asset Turnover | 0.66 |
| Inventory Turnover | 1.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.44% |
| 50-Day Moving Average | 69.72 |
| 200-Day Moving Average | 74.81 |
| Relative Strength Index (RSI) | 45.57 |
| Average Volume (20 Days) | 105,289 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EI- Nile Co. for Pharmaceuticals and Chemical Industries had revenue of EGP 885.62 million and earned 24.65 million in profits.
| Revenue | 885.62M |
| Gross Profit | 177.88M |
| Operating Income | 74.37M |
| Pretax Income | 26.46M |
| Net Income | 24.65M |
| EBITDA | n/a |
| EBIT | 74.37M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 17.16 million in cash and 505.39 million in debt, giving a net cash position of -488.23 million or -48.22 per share.
| Cash & Cash Equivalents | 17.16M |
| Total Debt | 505.39M |
| Net Cash | -488.23M |
| Net Cash Per Share | -48.22 |
| Equity (Book Value) | 457.12M |
| Book Value Per Share | n/a |
| Working Capital | 76.38M |
Cash Flow
In the last 12 months, operating cash flow was 247.51 million and capital expenditures -503.59 million, giving a free cash flow of -256.08 million.
| Operating Cash Flow | 247.51M |
| Capital Expenditures | -503.59M |
| Free Cash Flow | -256.08M |
| FCF Per Share | -25.29 |
Margins
Gross margin is 20.08%, with operating and profit margins of 8.40% and 2.78%.
| Gross Margin | 20.08% |
| Operating Margin | 8.40% |
| Pretax Margin | 2.99% |
| Profit Margin | 2.78% |
| EBITDA Margin | n/a |
| EBIT Margin | 8.40% |
| FCF Margin | -28.92% |
Dividends & Yields
This stock pays an annual dividend of 3.71, which amounts to a dividend yield of 6.39%.
| Dividend Per Share | 3.71 |
| Dividend Yield | 6.39% |
| Dividend Growth (YoY) | -25.80% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 261.23% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.39% |
| Earnings Yield | n/a |
| FCF Yield | -43.55% |
Stock Splits
The last stock split was on January 20, 2011. It was a forward split with a ratio of 1.5.
| Last Split Date | Jan 20, 2011 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |